Sanguinaria

From Wikipedia, the free encyclopedia
Bloodroot
Sanguinaria canadensis
Scientific classification
Kingdom: Plantae
Division: Magnoliophyta
Class: Magnoliopsida
Order: Ranunculales
Family: Papaveraceae
Genus: Sanguinaria
L.
Species: S. canadensis
Binomial name
Sanguinaria canadensis
L.

Sanguinaria canadensis, bloodroot, is a perennial, herbaceous flowering plant native to eastern North America. It is the only species in the genus Sanguinaria, included in the family Papaveraceae, and most closely related to Eomecon of eastern Asia.

Sanguinaria canadensis is also known as bloodwort, red puccoon root, and sometimes pauson. It has also been known as tetterwort in the US, although that name is used in Britain to refer to Chelidonium majus. Plants are variable in leaf and flower shape and have in the past been separated out as different subspecies due to these variable shapes. Currently most taxonomic treatments lump these different forms into one highly variable species. In bloodroot, the juice is red and poisonous.[1]

Description

Sanguinaria canadensis, is a variable species growing from 20–50 centimetres (7.9–19.7 in) tall, normally with one large, sheath-like basal multi-lobed leaf up to 12 centimetres (4.7 in) across. Bloodroot stores sap in an orange colored rhizome, that grows shallowly under or at the soil surface. Over many years of growth, the branching rhizome can grow into a large colony. Plants start to bloom before the foliage unfolds in early spring and after blooming the leaves expand to their full size and go summer dormant in mid to late summer.

The flowers are produced from March to May, with 8-12 delicate white petals and yellow reproductive parts. The flowers appear over clasping leaves while blooming. The flowers are pollinated by small bees and flies, seeds develop in elongated green pods 40 to 60 mm in length and ripen before the foliage goes dormant. The seeds are round in shape and when ripe are black to orange-red in color.

Distribution and habitat

Bloodroot is native to eastern North America from Nova Scotia, Canada southward to Florida, United States, and west to Great Lakes and down the Mississippi embayment.

Sanguinaria canadensis plants are found growing in moist to dry woods and thickets, often on flood plains and near shores or streams on slopes. They grow less frequently in clearings and meadows or on dunes, and are rarely found in disturbed sites. Deer will feed on the plants in early spring.

Ecology

Bloodroot is one of many plants whose seeds are spread by ants, a process called myrmecochory. The seeds have a fleshy organ called an elaiosome that attracts ants. The ants take the seeds to their nest, where they eat the elaiosomes, and put the seeds in their nest debris, where they are protected until they germinate. They also get the added bonus of growing in a medium made richer by the ant nest debris.

Cultivation

Sanguinaria canadensis is cultivated as an ornamental plant. The double flowering forms are prized by gardeners for their large showy white flowers, which are produced very early in the gardening season. Bloodroot flower petals are shed within a day or two of pollination so the flower display is short lived. The double forms bloom much longer than the normal forms, the double flowers are made up of stamens that have been changed into petal looking like parts, making pollination more difficult.

The cultivar S. canadensis f. multiplex 'Plena' has gained the Royal Horticultural Society's Award of Garden Merit.[2]

Toxicity

Bloodroot produces benzylisoquinoline alkaloids, primarily the toxin sanguinarine. The alkaloids are transported to and stored in the rhizome. Comparing the biosynthesis of morphine and sanguinarine, the final intermediate in common is (S)-reticuline.[3][4] A number of plants in Papaveraceae and Ranunculaceae, as well as plants in the genus Colchicum (family Colchicaceae) and genus Chondodendron (family Menispermaceae), also produce such benzylisoquinoline alkaloids.

Plant geneticists have identified and sequenced genes which produce the enzymes required for this production. One enzyme involved is CYP80B1,[5] which produces (S)-3'-hydroxy-N-methylcoclaurine and mendococlaurine from (S)-N-methylcoclaurine.

Toxicity to animal cells

Sanguinarine kills animal cells by blocking the action of Na+/K+-ATPase transmembrane proteins. As a result, applying bloodroot to the skin may destroy tissue and lead to the formation of a large scab, called an eschar. Bloodroot and its extracts are thus considered escharotic.

Internal use is inadvisable. Applying escharotic agents, including bloodroot, to the skin is sometimes suggested as a home treatment for skin cancer, these attempts can be severely disfiguring.[6] Salves derived from bloodroot cannot be relied on to remove an entire malignant tumor. Microscopic tumor deposits may remain after visible tumor tissue is burned away, and case reports have shown that in such instances tumor has recurred and/or metastasized.[7]

Numerous pre-clinical in vitro studies have demonstrated that sanguinarine causes targeted apoptosis in human cancer cells with little reaction from normal cells, and recommend future study of sanguinarine as a potential cancer treatment.[8]

Uses

Complementary and alternative medicine

Bloodroot was used historically by Native Americans for curative properties as an emetic, respiratory aid, and other treatments.[9]

In physician William Cook's 1869 work The Physiomedical Dispensatory is recorded a chapter on the uses and preparations of bloodroot,[10] which described tinctures and extractions, and also included at least the following cautionary report:

The U. S. Dispensatory says four persons lost their lives at Bellevue Hospital, New York, by drinking largely of blood root tincture in mistake for ardent spirits [...]

Greater Celandine (Chelidonium majus), a member of the Poppy family (Papaveraceae) was used in Colonial America as a wart remedy. Bloodroot has been similarly applied in the past. This may explain the multiple American and British definitions of "Tetterwort" in 1913.

Bloodroot extracts have also been promoted by some supplement companies as a treatment or cure for cancer, but the U.S. Food and Drug Administration has listed some of these products among its "187 Fake Cancer 'Cures' Consumers Should Avoid".[11] Indeed, far from curing cancer, products containing bloodroot are strongly associated with the development of oral leukoplakia,[12] which is a premalignant lesion that may develop into oral cancer.

Canada puccoon by Sydenham Edwards from The Botanical Magazine (1791)

Commercial uses

Commercial uses of sanguinarine and bloodroot extract include dental hygiene products. The United States FDA has approved the inclusion of sanguinarine in toothpastes as an antibacterial or anti-plaque agent.[13][14][15][16] However, the use of sanguinaria in oral hygiene products is associated with the development of oral leukoplakia, a premalignant lesion which may develop into oral cancer.[17][12] On 24 Nov 2003, the Colgate-Palmolive Company of Piscataway, New Jersey, United States commented by memorandum to the United States Food and Drug Administration that then-proposed rules for levels of sanguinarine in mouthwash and dental wash products were lower than necessary.[18] However, this conclusion is controversial.[19]

Some animal food additives sold and distributed in Europe such as Phytobiotics' Sangrovit contain sanguinarine and chelerythrine. On 14 May 2003, Cat Holmes reported in Georgia Faces[20] that Jim Affolter and Selima Campbell, horticulturists at the University of Georgia College of Agricultural and Environmental Sciences, were meeting with Phytobiotics to relate their research into commercial cultivation of bloodroot.

Plant dye

Bloodroot is a popular red natural dye used by Native American artists, especially among southeastern rivercane basketmakers.[21] The blood of the root (when cut open) was used as a dye. A break in the surface of the plant, especially the roots, reveals a reddish sap.

See also

References

  1. "Bloodroot Wildflowers". 
  2. "RHS Plant Selector - Sanguinaria canadensis f. multiplex 'Plena'". Retrieved 03 July 2013. 
  3. Alcantara, Joenel; Bird, David A.; Franceschi, Vincent R.; Facchini, Peter J. (2005). "Sanguinarine Biosynthesis is Associated with the Endoplasmic Reticulum in Cultured Opium Poppy Cells after Elicitor Treatment". Plant Physiology 138 (1): 173–83. doi:10.1104/pp.105.059287. JSTOR 4629815. PMC 1104173. PMID 15849302. 
  4. KEGG PATHWAY: Alkaloid biosynthesis I - Reference pathway
  5. KEGG ENZYME: 1.14.13.71
  6. Don't Use Corrosive Cancer Salves (Escharotics), Stephen Barrett, M.D.
  7. McDaniel, S.; Goldman, GD (2002). "Consequences of Using Escharotic Agents as Primary Treatment for Nonmelanoma Skin Cancer". Archives of Dermatology 138 (12): 1593–6. doi:10.1001/archderm.138.12.1593. PMID 12472348. 
  8. Han, M.H.; Park, C.; Jin, C.-Y.; Kim, G.-Y.; Chang, Y.-C.; Moon, S.-K.; Kim, W.-J.; Choi, Y.H. (2013). "Apoptosis Induction of Human Bladder Cancer Cells by Sanguinarine through Reactive Oxygen Species-Mediated Up-Regulation of Early Growth Response Gene-1". PLoS ONE 8 (5): e63425. doi:10.1371/journal.pone.0063425. 
  9. Native American Ethnobotany (University of Michigan - Dearborn: Sanguinaria canadensis' . accessed 12.1.2011
  10. Sanguinaria Canadensis'. | Henriette's Herbal Homepage
  11. "187 Fake Cancer "Cures" Consumers Should Avoid". United States Food and Drug Administration. Retrieved 2010-04-15. 
  12. 12.0 12.1 Bouquot, Brad W. Neville , Douglas D. Damm, Carl M. Allen, Jerry E. (2002). Oral & maxillofacial pathology (2. ed. ed.). Philadelphia: W.B. Saunders. p. 338. ISBN 0721690033. 
  13. Godowski, KC (1989). "Antimicrobial action of sanguinarine". The Journal of clinical dentistry 1 (4): 96–101. PMID 2700895. 
  14. Southard, GL; Boulware, RT; Walborn, DR; Groznik, WJ; Thorne, EE; Yankell, SL (1984). "Sanguinarine, a new antiplaque agent: Retention and plaque specificity". Journal of the American Dental Association 108 (3): 338–41. PMID 6585404. 
  15. How to Report Problems With Products Regulated by FDA
  16. Kuftinec, MM; Mueller-Joseph, LJ; Kopczyk, RA (1990). "Sanguinaria toothpaste and oral rinse regimen clinical efficacy in short- and long-term trials". Journal of the Canadian Dental Association 56 (7 Suppl): 31–3. PMID 2207852. 
  17. Leukoplakia, (pdf format) hosted by the American Academy of Oral and Maxillofacial Pathology. Page accessed on December 19, 2006.
  18. Letter to FDA, Collgate-Palmolive Company, 24 Nov. 2003
  19. Letter to FDA, Professor George T. Gallagher, Boston University Goldman School of Dental Medicine, 23 June 2003.
  20. Georgia FACES
  21. Nolan, Justin. "Northeast Oklahoma, USA." Society of Ethnobotany. 2007 (retrieved 9 Jan 2011)

Gallery

External links


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.